University of British Columbia; British Columbia Centre for Disease Control
Mel Krajden MD, FRCPC is the Director of BC’s Public Health Laboratory and the Medical Head, Hepatitis at the British Columbia Centre for Disease Control. He is also a Professor of Pathology and Laboratory Medicine at the University of British Columbia. His clinical research involves hepatitis molecular and health systems research and his laboratory research focuses on the application of molecular techniques to: diagnose viruses; assess correlates between infection and clinical disease; monitor antiviral efficacy and track microbial infections for epidemiological purposes. This has included serological assay development related to human papilloma virus. He has been awarded CIHR funding in the fields of human papillomavirus, HIV and hepatitis C. He was co-applicant on a CDN$6.8 M Canadian Institutes of Health Research (CIHR) funded HPV “Focal Trial” which was designed to determine if primary HPV DNA screening can replace Pap smears and/or co-testing as a screening modality.